Madrid, Spain

Álvaro Acebrón Fernández


 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 54(Granted Patents)


Location History:

  • Madrid, ES (2012 - 2014)
  • Alcobendas, ES (2014)
  • Alcobendas-Madrid, ES (2015)

Company Filing History:


Years Active: 2012-2015

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Álvaro Acebrón Fernández

Introduction

Álvaro Acebrón Fernández is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of vaginal atrophy. With a total of 4 patents, his work focuses on innovative solutions for women facing various health risks.

Latest Patents

One of his latest patents is related to the treatment of vaginal atrophy in women with tumor pathology risk. This invention involves the use of estriol in a pharmaceutical formulation designed for vaginal administration. The formulation is capable of self-limiting the absorption of estriol, aimed at preventing and treating urogenital atrophy in women who are at high risk of developing estrogen-dependent tumors. Another significant patent addresses the treatment of vaginal atrophy in women with cardiovascular pathology risk. Similar to the previous invention, this formulation also utilizes estriol and is intended for women who have a high probability of suffering from cardiovascular issues.

Career Highlights

Throughout his career, Álvaro has worked with reputable companies such as Itf Research Pharma and Italfarmaco. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

He has collaborated with professionals like Dolores Blanco Lousame and Jaime Moscoso Del Prado, enhancing his research and development efforts.

Conclusion

Álvaro Acebrón Fernández continues to be a significant figure in the field of pharmaceutical inventions, focusing on treatments that address critical health issues for women. His innovative patents reflect his commitment to improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…